Galapagos
Mechelen-bovelingen · Founded 1999
About Galapagos
Galapagos is a clinical-stage biotechnology company, specialized in the discovery and development of small molecule medicines with novel modes of action. Our ambition is to become a leading global biopharmaceutical company, focused on the discovery, development and commercialization of innovative medicines that will improve people's lives.
Company Facts
- Founded: 1999
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 251 – 500
- Estimated revenue: $500K – $1M
- Total funding: $5.4B
- Funding stage: IPO
- Last round: Post-IPO Equity (Jul 2019)
- Ticker: ebr:GLPG
- Website: glpg.com
- Phone: +32 15 34 29 00
Industries & Categories
Biopharma, Biotechnology, Clinical Trials, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/galapagos-5683 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.